Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

Jichi Medical University (自治医科大学 Jichi ika daigaku) is a private university in Shimotsuke, Tochigi, Japan, established in 1972. In 2008 the Gates Foundation awarded $100,000 to Hiroyuki Matsuoka, a medical researcher at the university, to do research on flying syringes.

The Carlos III Health Institute (Spanish: Instituto de Salud Carlos III; ISCIII) is a Spanish public health research institute, legally constituted as a public research agency (Spanish: Organismo Público de Investigación), a type of quasi-autonomous entity under Spanish law. The agency is integrated in the Department of Science and Innovation, although it also reports to the Department of Health in the institute's activities relating health, healthcare and its planning.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Jiangsu Academy of Agricultural Sciences is a Chinese private company located in Nanjing, with subsidiaries in China, that engages in agriculture research and development.

HuBit Genomix KK is a Japanese company located in Tokyo specializing in commercial physical and biological research. Celera Group acquired HuBit Genomix KK on March 20, 2001.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Readline is a bio-pharmaceutical high-tech company with a multidisciplinary application based on enzyme catalysis technology. It is the world's first company to use directed evolution of enzymes in the large-scale production of API such as peptides, carbohydrate, and nucleic acids on an all-green basis. These APIs are primarily used in medicine, health care products, cosmetics, animal feed, biological pesticides, fertilizers, and other applications.

Jinan Dengyide Technology and Trade Co., Ltd., established on 2006-08-21, Business scope includes licensed business items:Three categories:6846Implantable materials and artificial organs;two,Three categories:6821Medical electronic equipment,6823Medical Ultrasonic Instruments and Related Equipment,6830medicalxX-ray equipment(Valid until2016-9-12);General operating items:Development of Medical Devices,consultation service,technology transfer,Maintenance service.(subject to approval,Do not operate without approval)

Jiangsu Trautec Medical Technology Co., Ltd. is a company headquartered in China that engages in developing recombinant collagen biomaterials.

Wuhan Keqian Biology is involved in the research and development, production, and sale of veterinary biological products, as well as the provision of technical services for the prevention of animal epidemics. They offer products including a combination vaccine, a vaccine for poultry, a pet vaccine, and a diagnostic reagent.

University Health Network (UHN) is a healthcare and medical research organization in Toronto, Ontario, Canada. It is the largest such research organization in Canada and North America, ranking first in Canada for total research funding. It was named Canada's top research hospital by Research Infosource in 2015, 2016 and 2017. It was created in 1986 by the Government of Ontario through the merger of four major hospitals: Toronto General Hospital, Toronto Western Hospital, with the Princess Margaret Cancer Centre, and the Toronto Rehabilitation Institute merged in with The Toronto Hospital in 1999 and the name changed to the University Health Network. All four hospitals are affiliated with the Faculty of Medicine at the University of Toronto and serve as teaching hospitals for resident physicians, nurses, and other healthcare professions. UHN also operates The Michener Institute, an applied health sciences college that opened in 1958.

The Texas A&M University System creates a seamless pathway for students to earn an associate and bachelor’s degree in related fields

Shanghai Maitai Junao Biotechnology Co., Ltd., established on 2012-05-30, Business scope includes general items:Biomedical Technology,Technology development in the field of detection technology,technical consulting,Technical Services,technology transfer,Specialty Chemicals(Free of Hazardous Chemicals),Manufacture and sale of bio-based materials,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals)promotion of,Engaged in the import and export of goods and technology.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Chongqing Paijin Biotechnology Co., Ltd., established on 2013-03-28, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Biochemical product technology research and development,Fermentation process optimization technology research and development,Engineering and Technology Research and Experimental Development,Medical Research and Experimental Development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Diandou Gene Technology (Nanjing) Co., Ltd., established on 2018-03-21, Business scope includes technology research and development in the genetic field,Technical Services,technology transfer,technical consulting;Biotechnology R&D,Technical Services,technology transfer,technical consulting;R&D and sales of medical devices(Operating with a license involving licensing);Self-operated and agent import and export business of various commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Cosmetics Retail;Cosmetics Wholesale;internet sales(Except for products that require a license for sale);Sales of Class I Medical Devices;Sales of Class II Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)